mrps-18C Antibody

What is MRPS18C and why is it significant in research?

MRPS18C (Mitochondrial Ribosomal Protein S18C) is a component of the mitochondrial ribosome's small subunit. This protein plays a crucial role in mitochondrial protein synthesis and function. Research on MRPS18C contributes to understanding mitochondrial translation, ribosome assembly, and potential implications in diseases associated with mitochondrial dysfunction. The protein appears in multiple forms including 28S ribosomal protein S18-1 and S18c (mitochondrial), also known as MRP-S18-1, MRP-S18-c, S18mt-c, and small ribosomal subunit protein bS18c/bS18m .

What molecular characteristics should researchers know about MRPS18C antibodies?

MRPS18C antibodies are primarily available as rabbit polyclonal antibodies targeting various epitopes of the human protein. These antibodies detect a protein with a molecular weight of approximately 15 kDa. The antibodies are typically generated against specific amino acid sequences (such as AA 71-120 or AA 1-142) or full-length fusion proteins of human MRPS18C . Understanding the target epitope is crucial for experimental design, especially when investigating specific domains or when epitope accessibility may be affected by protein interactions or post-translational modifications.

What species cross-reactivity do MRPS18C antibodies exhibit?

Most commercially available MRPS18C antibodies demonstrate reactivity with human samples. Some antibodies also cross-react with mouse and rat samples, while others may react with additional species such as monkey . When designing experiments with animal models, researchers should carefully verify the documented species reactivity for their specific antibody and validate cross-reactivity experimentally before proceeding with full-scale studies.

What validated applications are available for MRPS18C antibodies?

MRPS18C antibodies have been validated for multiple applications including:

• Western Blotting (WB)

• Immunohistochemistry (IHC)

• Immunocytochemistry/Immunofluorescence (ICC/IF)

• Enzyme-Linked Immunosorbent Assay (ELISA)

Researchers should review validation data for their specific application and optimize protocols accordingly. The choice of application depends on whether researchers are investigating protein expression levels, localization patterns, or protein-protein interactions.

What are the optimal conditions for Western blotting with MRPS18C antibodies?

For optimal Western blotting results with MRPS18C antibodies:

The antibody should detect a band at approximately 15 kDa, corresponding to MRPS18C . Validation data shows successful detection in multiple cell lines including HeLa, K562, and 231 cells, as well as human bladder carcinoma tissue .

What protocol modifications are recommended for immunohistochemistry with MRPS18C antibodies?

For immunohistochemistry applications:

• Use paraffin-embedded tissue sections

• Perform antigen retrieval (typically heat-induced epitope retrieval with citrate buffer)

• Block with appropriate blocking solution (typically 5% normal serum)

• Dilute primary antibody 1:50 to 1:200 depending on the specific antibody

• Incubate overnight at 4°C

• Use an appropriate detection system compatible with rabbit primary antibodies

Human breast tissue sections have been successfully stained with MRPS18C antibodies, demonstrating the expected mitochondrial localization pattern .

How can researchers validate the specificity of MRPS18C antibodies?

To validate antibody specificity, researchers should:

• Confirm a single band at 15 kDa in Western blot analysis

• Perform peptide competition assays using the immunizing peptide

• Compare staining patterns across multiple antibodies targeting different MRPS18C epitopes

• Use MRPS18C-depleted samples (siRNA knockdown or CRISPR knockout) as negative controls

• Verify subcellular localization is consistent with expected mitochondrial distribution

• Include appropriate isotype controls in IHC/IF experiments

These validation steps are essential to ensure experimental results accurately reflect MRPS18C biology rather than non-specific antibody interactions.

What factors might affect MRPS18C detection in experimental systems?

Several factors can influence MRPS18C detection:

• Fixation methods: Overfixation may mask epitopes; optimize fixation time

• Mitochondrial integrity: Mitochondrial isolation techniques may affect protein accessibility

• Post-translational modifications: May alter epitope recognition depending on the antibody

• Sample preparation: Denaturation conditions in Western blotting may affect antibody binding

• Mitochondrial content variability: Expression levels may correlate with mitochondrial abundance

• Cell/tissue metabolic state: May influence mitochondrial protein expression levels

Researchers should consider these factors when troubleshooting experiments or when comparing results across different experimental conditions.

How should researchers interpret heterogeneous staining patterns in tissue samples?

When encountering heterogeneous MRPS18C staining patterns:

• Correlate with mitochondrial markers to determine if the pattern reflects mitochondrial distribution

• Quantify staining across multiple regions and samples for statistical analysis

• Perform dual staining with cell type-specific markers to identify patterns in specific cell populations

• Compare with functional mitochondrial assays (e.g., respiratory capacity)

• Consider biological variability in mitochondrial content between different cell types

• Validate observations with complementary methods (e.g., in situ hybridization)

Heterogeneous patterns may reflect biological variability rather than technical artifacts, potentially providing insights into tissue-specific mitochondrial functions.

What controls should be included in MRPS18C antibody experiments?

For rigorous experimental design, include:

• Positive control: Tissues/cells known to express MRPS18C (e.g., HeLa cells)

• Negative control: Sections/lysates incubated with isotype-matched IgG instead of primary antibody

• Absorption control: Primary antibody pre-incubated with excess immunizing peptide

• Loading control: For Western blots, include both general (β-actin) and mitochondrial-specific (VDAC) controls

• Subcellular marker: Include mitochondrial markers to confirm proper localization

These controls help distinguish specific signals from background and validate experimental findings.

How can researchers troubleshoot non-specific binding with MRPS18C antibodies?

To address non-specific binding:

• Optimize blocking conditions (increase concentration to 5% BSA or milk)

• Increase antibody dilution (test series from 1:500 to 1:2000)

• Extend washing steps (more frequent changes and longer durations)

• Pre-absorb antibody with the immunizing peptide

• Try alternative blocking agents (fish gelatin or commercial blockers)

• For IHC/IF, include a secondary-only control to identify non-specific secondary binding

• Consider using purified antibody fractions (affinity-purified antibodies show >95% purity)

Systematic optimization of these parameters can significantly improve signal-to-noise ratio.

What methodologies are recommended for studying MRPS18C interactions with other mitochondrial proteins?

To investigate protein-protein interactions involving MRPS18C:

• Co-immunoprecipitation using MRPS18C antibodies followed by Western blotting or mass spectrometry

• Proximity ligation assay (PLA) for visualizing interactions in situ

• Sucrose gradient fractionation to study mitochondrial ribosome assembly

• Crosslinking approaches to capture transient interactions

• Blue native gel electrophoresis to preserve native protein complexes

• Immunofluorescence co-localization with super-resolution microscopy

These approaches provide complementary information about MRPS18C's role in mitochondrial ribosome assembly and function.

How can researchers apply MRPS18C antibodies in studies of mitochondrial dysfunction?

For investigating mitochondrial dysfunction:

• Monitor MRPS18C expression changes in response to mitochondrial stressors

• Compare MRPS18C levels in normal versus diseased tissues

• Assess mitochondrial ribosome integrity using fractionation approaches

• Correlate MRPS18C expression with mitochondrial translation efficiency

• Examine MRPS18C subcellular distribution under stress conditions

• Investigate potential post-translational modifications affecting MRPS18C function

These approaches can provide insights into how mitochondrial translation machinery responds to pathological conditions.

What considerations are important when selecting secondary antibodies for MRPS18C detection?

For optimal secondary antibody selection:

• Match host species to the primary antibody (anti-rabbit for MRPS18C rabbit polyclonals)

• Choose appropriate conjugation based on detection method:

  • HRP for chemiluminescent Western blotting

  • Fluorophores (FITC, Alexa Fluor) for immunofluorescence

  • Biotin for signal amplification in IHC

• Consider cross-adsorption properties to minimize background

• Validate secondary antibody specificity independently

• Several validated options include goat anti-rabbit IgG antibodies with AP, biotin, FITC, or HRP conjugations

Proper secondary antibody selection is crucial for detection sensitivity and specificity.

How might post-translational modifications affect MRPS18C antibody recognition?

Post-translational modifications may impact antibody binding depending on:

• Location of modifications relative to the antibody epitope

• Nature of the modification (phosphorylation, acetylation, ubiquitination)

• Conformational changes induced by modifications

• Sample preparation methods that may preserve or disrupt modifications

Researchers investigating post-translational regulation should:

• Use multiple antibodies targeting different epitopes

• Consider phosphatase or deacetylase treatment to remove modifications

• Employ modification-specific antibodies when available

• Use mass spectrometry to identify and characterize modifications